May 23rd, 2008
(Image credit www.about.com)
A University of Carolina study monitoring 1200 newborns from the ‘Isle of Wight cohort’ found that first borns were more likely to carry a gene variant which raised their risk of developing an allergy before the age of 10. The study suggested that a first born experienced different conditions in the uterus from subsequent siblings.
The […]
By Elaine -- 2 comments
April 20th, 2008
MRI of a migraine
Migraine is the most common cause of episodic headache, and by far the most common neurological cause of a doctor’s visit. It affects some 15% of the world’s population.
Researchers from Helsinki University, Finland and the Sanger Institute, UK were able for the first time to convincingly demonstrate a genomic locus to be linked to […]
By Elaine -- 0 comments
April 12th, 2008
G&H’s INTERVIEW WITH NAVIGENICS
Navigenics approached Genetics and Health for an interview. With so much written about similar genomics companies such as 23andme, Knome, deCODE genetics, I was intrigued to learn more about this company. In particular, Navigenics appears to be the only company within this industry genre who provides a comprehensive wellness model – a […]
By Elaine -- 3 comments
April 9th, 2008
In this third article originating from G&H’s exclusive interview with Navigenics’ Medical Director, Dr Michael Nierenberg, we explore the whole issue of SNP testing and how SNPs can be used in disease risk assessment.
Navigenics has focused on around 100 of the most definitive research papers on SNPs (single nucleotide polymorphisms) that have been most strongly associated […]
By Elaine -- 2 comments
April 4th, 2008
A research team comprising scientists from MD Anderson, Johns Hopkins University and the Insitutute for Cancer Research and the University of Cambridge, UK have identified two inherited genetic variations (SNPs) on chromosome 15 associated with increased risk of lung cancer for smokers and former smokers. Individuals who have ever […]
By Elaine -- 1 comment
April 3rd, 2008
Icelandic company deCode Genetics has announced it has signed a Letter of Intent to offer its genetic testing products to US Preventative Medicine customers.
US Preventative Medicine is a Dallas based company. The company has developed a suite of prevention, early detection and chronic condition management products and services that improve health outcomes while reducing health […]
By Elaine -- 0 comments
April 3rd, 2008
(Courtesy of WAMU 88.5 FM American University Radio, Washington, USA)
This is a really interesting radio clip from The Diana Rehm Show on WAMU radio on the whole issue of personal genetics.
http://wamu.org/programs/dr/08/04/01.php#20091 and click on either the real audio or windows media buttons
“A growing number of people are turning to personalized genetic testing to learn about possible predisposition […]
By Elaine -- 0 comments
March 19th, 2008
Many gene studies focus on WHICH genes cause a person’s risk of developing a disease (forward genetics) but few focus on HOW those genes can lead to disease. Researchers at Merck and Co, deCODE genetics and academic centres in the US and France have focused on the latter and shed light on the complexity of common disease causes where […]
By Elaine -- 1 comment
March 18th, 2008
In January, The New England Journal of Medicine published an article criticizing the popularization of genetic testing by companies such as 23andme, deCode, Navigenics and Knome who doctors believe are introducing genetic testing prematurely into a commercial setting and confusing public and medics alike. The authors of this article coined the phrase ‘recreational genomics’ for this type of testing.
While […]
By Elaine -- 3 comments
March 18th, 2008
I’ve known UK diagnostics company Lab-21 for some years now. My previous company Opaldia and Lab-21 effectively ‘grew up’ together.
Amgen Limited UK and Lab21 have announced their partnership to introduce a new genetic therapy test for advanced bowel cancer treatment. Under the terms of the agreement, Lab21 will provide a screening test to indicate which patients are likely […]
By Elaine -- 0 comments
Recent Comments